W.L. Gore & Associates announced today that it agreed to acquire left atrial appendage occlusion (LAAO) device maker ...

W. L. Gore & Associates (Gore) has acquired Conformal Medical in bid to strengthen the US multinational’s endovascular ...

Global materials science company W. L. Gore & Associates has reached an agreement to acquire Conformal Medical, a medtech ...

W L Gore & Associates to acquire medical device company, Conformal Medical to expand its presence in endovascular treatments: Newark, Delaware Wednesday, January 7, 2026, 15:00 Hr ...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...

A team of specialists at Jacksonville, Fla.-based Baptist Health has become the first in the U.S.’ Southeast region to implant the Amplatzer Amulet Left Atrial Appendage Occluder. The device is meant ...

New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation ...

TCT 418: High-Volume Cath Lab Insights: CTCA’s Superior Vessel-Specific Concordance in Noninvasive Ischemia Testing — An 18-Month Tertiary Center Experience in Piraeus, Greece Receive the the latest ...

VIENNA, AUSTRIA — Thrombi were sometimes found on two left-atrial-appendage (LAA) occluder devices in the weeks following implantation in two large registry studies of patients with atrial ...

On Saturday, Boston Scientific Corporation (NYSE:BSX) unveiled three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device ...